Komal Pediatric And Neonatal Criticare And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 06-07-2024
- Paid Up Capital ₹ 0.62 M
as on 06-07-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 0.70 M
as on 06-07-2024
- Revenue %
(FY 2022)
- Profit -57.53%
(FY 2022)
- Ebitda -9.52%
(FY 2022)
- Net Worth -0.42%
(FY 2022)
- Total Assets -2.50%
(FY 2022)
About Komal Pediatric And Neonatal Criticare And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.62 M.
The company has closed loans amounting to ₹0.70 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sharwari Mirgunde, Shobha Oswal, Prasad Tengshe, and Four other members serve as directors at the Company.
- CIN/LLPIN
U85110PN2004PTC019370
- Company No.
019370
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Komal Pediatric And Neonatal Criticare And Research Centre?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharwari Mirgunde  | Director | 01-Feb-2017 | Current |
| Shobha Oswal | Director | 01-Feb-2017 | Current |
| Prasad Tengshe | Director | 08-Jun-2004 | Current |
| Abhijeet Patil | Director | 08-Jun-2004 | Current |
| Ramesh Nigade | Director | 08-Jun-2004 | Current |
| Prakash Sanghavi | Director | 08-Jun-2004 | Current |
Financial Performance of Komal Pediatric And Neonatal Criticare And Research Centre.
Komal Pediatric And Neonatal Criticare And Research Centre Private, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 57.53% decrease in profit. The company's net worth dipped by a decrease of 0.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Komal Pediatric And Neonatal Criticare And Research Centre?
In 2020, Komal Pediatric And Neonatal Criticare And Research Centre had a promoter holding of 99.74% and a public holding of 0.26%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Parisparsha Swasthya Mantra Centre Private LimitedActive 7 years 1 month
Shobha Oswal is a mutual person
- Komalswastik Healthcare Private LimitedActive 5 years 7 months
Prasad Tengshe, Abhijeet Patil and 3 more are mutual person
- Kolhapur Medical And Analogical Research Centre Private LimitedActive 34 years 8 months
Prakash Sanghavi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The United Western Bank Ltd Creation Date: 29 Mar 2005 | ₹0.70 M | Satisfied |
How Many Employees Work at Komal Pediatric And Neonatal Criticare And Research Centre?
Unlock and access historical data on people associated with Komal Pediatric And Neonatal Criticare And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Komal Pediatric And Neonatal Criticare And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Komal Pediatric And Neonatal Criticare And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
